BPC-157 Peptide: Why Interest Is High While Human Research Is Still Behind

Introduction

NAD+ and peptides like BPC-157 and GHK-Cu show up in wellness feeds constantly, usually with big promises attached. Here at BabyFace, we offer these compounds using PushPatch® technology, so we think you deserve a straight account of what the scientific evidence supports.

BPC-157: Promising, but Mostly in Animals

BPC means “Body Protection Compound.” BPC-157 is a synthetic peptide modeled on a protein fragment originally identified in gastric juice. Researchers became interested in it because the stomach lining can repair itself remarkably well.

Although many human case reports and personal accounts exist, well-designed clinical trials in humans remain limited. Most available research has been conducted on rats and mice, with findings suggesting potential benefits for tendon and ligament healing, gut protection, muscle repair, and circulation.

There are currently small human trials on BPC-157 and a Phase 2 clinical trial examining BPC-157 for acute hamstring injury that began recruiting in 2026. That is a positive sign of scientific interest. Results have not yet been published.

NAD+: A Coenzyme With a Clear Role

NAD+ is a coenzyme, not a peptide. In the body, it supports energy production, DNA repair, and cellular stress response, and levels decline with age. Research connects NAD+ to cellular energy and resilience, as well as to energy, focus and recovery.

One caveat applies. Much of the NAD+ research looks at its role inside cells or at oral precursors, and studies on patch delivery specifically have not caught up.

Why GHK-Cu (Copper Peptide) Joins Them

GHK-Cu supports structural rebuilding and collagen, and NAD+ supplies cellular energy for the work.

Who Should Skip It: A Cautionary Approach

  • People with active cancer, or anyone behind on cancer screenings

  • People with Wilson's disease or other copper metabolism disorders

  • Anyone with cherry angiomas or hemangiomas, since BPC-157 may worsen certain vascular issues

  • Anyone who is pregnant or breastfeeding

Reported side effects include patch-site skin irritation, fluid retention, and occasional mood changes that resolve after stopping. BPC-157 is also not meant for indefinite use.

One proposed mechanism of BPC-157 is its influence on VEGF, a growth factor that supports new blood vessel formation. More blood flow could help poorly supplied tissue like tendons. BPC-157 appears to stimulate VEGF and blood vessel growth in animal models, but there is no confirmed human evidence, and while tumor-growth promotion is biologically plausible in theory, it has not been demonstrated in clinical studies.

The Importance of Quality and Supervision

Peptide sourcing matters. We only work with pharmacy-grade compounds from legit pharmacies that undergo proper testing and quality control.

FAQs

Does BPC-157 increase growth hormone?
No. It works through pathways related to tissue repair.

Can it replace medical treatment for an injury?
No. It complements care and does not substitute for it.

How soon will I notice something?
Some people report changes within days for acute injuries. Chronic concerns can take weeks, and individual responses vary.

Learn More at BabyFace

Read Peptide Therapy at BabyFace, BPC-157: Why Everyone Is Talking About This Tissue Repair Peptide, and Evidence-Based Supplement Guide.

Conclusion

While effective, injections can be uncomfortable and create fluctuating, short-lived levels of compounds in the body. BabyFace LC in Scottsdale offers a steady-delivery, ready-to-use 12-hour PushPatch® containing NAD+, BPC-157, and GHK-Cu in a needle-free format designed for extended wear.

If you want to learn whether they fit your history and goals, schedule a consultation at BabyFace. You can also take our free Persona Nutrition assessment or book time with Michael to review the supplements you already take.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. These statements have not been evaluated by the FDA. Services are not intended to diagnose, treat, cure, or prevent disease. Peptide therapy may not be appropriate for everyone. Individual results may vary.